Myriad Genetics Group

Operating company

HQ: United States

Total cases

Claimant-side

Respondent-side

Myriad Genetics Group has been party to eight Unified Patent Court cases, 3 times as claimant and 5 times as respondent. The most recent on record is UPC CoA 32/2026 at the Court of Appeal. Its most recent decision on the merits was in UPC CFI 437/2024 at the Munich Local Division on 19 December 2025: no infringement found.

Group members

8 entities · 8 cases combined

Top opponents

GXD-Bio Corporation8

More opponents

Top opponent firms

Vossius & Brinkhof UPC Litigators6

More opposing firms

Top firms retained

Hoffmann Eitle6

More of its firms

Start 14-day free trialEvery opponent and every firm acting for and against Myriad Genetics Group.Already a user? Sign in

Recent cases

Latest filings involving this group and its entities.

View all cases

2026-02-19UPC CoA 32/2026Court of Appeal—GXD-Bio Corporation v Eurobio Scientific GmbH
2026-02-19UPC CoA 33/2026Court of Appeal—GXD-Bio Corporation v Eurobio Scientific GmbH
2026-01-19UPC CFI 192/2026Munich LD—Myriad International GmbH v GXD-Bio Corporation
2026-01-19UPC CFI 195/2026Munich LDCosts onlyMyriad Genetics S.A.S. v GXD-Bio Corporation
2024-11-08UPC CFI 681/2024Munich LDPatent revokedMyriad Genetics S.A.S. v GXD-Bio Corporation
2024-07-25UPC CFI 437/2024Munich LDNo infringementGXD-Bio Corporation v Myriad International GmbH
—UPC APP 51844/2024Munich LDClaim dismissedGXD-Bio Corporation v Myriad International GmbH
—UPC APP 59539/2024Munich LDProcedural onlyGXD-Bio Corporation v Myriad International GmbH